U.S. Healthtech Stock News

Recent commentary around Snowflake (SNOW) has turned more cautious, as some analysts flag AI disruption risks and a tilt in software budgets toward AI native tools, just as the company prepares its next earnings update. See our latest analysis for Snowflake. The recent 4.2% one day share price decline and 33.6% 90 day share price return decline suggest momentum has cooled, even as Snowflake promotes new AI agent capabilities and prepares for its upcoming earnings update. If you are...

If you are wondering whether Hartford Insurance Group at around US$134.45 is offering fair value or a margin of safety, you are in the right place. The stock has been choppy in the short term, with a 3.9% decline over the last 7 days, a modest 1.6% return over 30 days, and a 1.9% year to date decline, while the 1 year return sits at 15.1% and the 3 year and 5 year returns are 100.5% and 125.5% respectively. These moves have kept Hartford on the radar for investors watching insurers,...

Wondering if Stride at around US$98.12 still offers value or if the best days are already priced in? This article breaks down what the numbers are really saying about the stock. The share price has been volatile, with a 0.3% slip over the last 7 days, a 14.6% gain over 30 days, a 51.9% return year to date, a 30.4% decline over the past year, and a 128.4% return over 3 years, alongside a 242.7% return over 5 years. Recent coverage has focused on how Stride fits into investor watchlists and...

This article examines whether A. O. Smith at around US$64 per share appears fairly priced or potentially offers value, by exploring what the current market price might be implying about the company. Over the last year the stock has returned 1.1%. In the shorter term, it has declined 0.7% over 7 days and 0.1% over 30 days, which may indicate that expectations and risk perception are still settling. Recent attention on A. O. Smith has focused on its role in capital goods and building-related...

Recent performance snapshot for XPEL XPEL (XPEL) has seen mixed share performance recently, with a small 1 day decline, a similar move over the past week, a gain over the past month, and weaker returns over the past 3 months. Over longer periods, the stock shows a gain on a 1 year total return basis. However, 3 year and 5 year total returns are negative, giving investors a varied picture of how the company has traded through different market conditions. See our latest analysis for XPEL. With...

OGE Energy (OGE) drew investor attention after reporting strong third quarter results, highlighting robust energy demand, customer growth, and an expectation to finish 2024 at the high end of its original earnings guidance. See our latest analysis for OGE Energy. At a share price of US$47.10, OGE Energy has seen an 8.85% 90 day share price return and a 9.03% 1 year total shareholder return. This suggests recent momentum has picked up around its third quarter earnings update and ongoing grid...

Why the latest quarter is in focus for Strategic Education Strategic Education (STRA) is back in the spotlight after first quarter 2026 earnings fell short of analyst expectations, with flat sales and softer enrollment trends prompting a sharp share price reaction. The company reported revenue of US$305.93 million and net income of US$32.81 million for the quarter ended March 31, 2026. A slight decrease in consolidated enrollment weighed on results. See our latest analysis for Strategic...

SEI Investments Company recently reported first-quarter 2026 results showing revenue of US$622.18 million and net income of US$174.49 million, with both basic and diluted earnings per share from continuing operations higher than a year earlier. Alongside these results, SEI continued its long-running share repurchase program, buying back 2,600,000 shares in the quarter, and expanded its digitized SEI Access platform to streamline collective investment trust onboarding for retirement market...

Immunocore Holdings (IMCR) has put fresh clinical data in front of investors, reporting five-year overall survival results for KIMMTRAK in metastatic uveal melanoma at the AACR 2026 meeting, with survival rates higher than the control arm. See our latest analysis for Immunocore Holdings. The fresh KIMMTRAK data lands after a mixed stretch in the market, with a 1 day share price return of 0.24%, a 90 day share price decline of 16.43%, and a 1 year total shareholder return decline of 2.85%...

Why the Atlanta BlueCity deal matters for Ouster (OUST) Ouster (OUST) is back on watch after Georgia's Department of Transportation chose its BlueCity lidar platform for more than 30 Atlanta intersections, extending an earlier six intersection deployment near the Georgia World Congress Center. For investors, this kind of municipal rollout highlights how Ouster's smart infrastructure offering is being adopted for real-world use. Agencies are replacing older inductive loops and 2D sensors with...

Kaspi.kz (NasdaqGS:KSPI) is back in focus after issuing US$600 million of senior unsecured notes due 2031, its second deal since reaching Investment Grade status and reportedly 3.5x oversubscribed by institutional buyers. See our latest analysis for Kaspi.kz. The latest US$600 million bond issue and the recent dividend affirmation come as Kaspi.kz’s share price trades at US$85.78, with a 30 day share price return of 21.04% and a 5 year total shareholder return of 51.06%. This suggests...

HCA Healthcare, Inc. has reported past first-quarter 2026 results showing sales of US$19.11 billion, net income of US$1.62 billion, diluted EPS of US$7.15, and declared a quarterly dividend of US$0.78 per share payable on June 30, 2026. The quarter highlighted how lower respiratory-related volumes and weather disruptions were largely offset by higher state supplemental payments, allowing HCA to reaffirm its full-year outlook while continuing investments in cost savings, network growth, and...

Oaktree Capital Management, led by Howard Marks, has increased its stake in Talen Energy (NasdaqGS:TLN). The move centers on Talen's energy and computing infrastructure assets at a time of rising electricity demand. The investment highlights external interest in Talen's role as a provider of power generation and related infrastructure. Talen Energy focuses on power generation and infrastructure that supports both traditional electricity needs and computing workloads. With demand for power...

LiveRamp Holdings (RAMP) is back in focus after DIRECTV Advertising expanded its use of LiveRamp's Conversions API Hub, aiming to offer secure, server to server attribution and real time closed loop measurement. See our latest analysis for LiveRamp Holdings. The expanded DIRECTV Advertising integration comes as LiveRamp’s 1 month share price return of 13.72% and 3 month share price return of 11.73% point to building momentum, while the 5 year total shareholder return of 40.28% loss shows...

Autoliv’s latest earnings and what they mean for investors Autoliv (ALV) reported first quarter 2026 results with sales of US$2,753 million and net income of US$141 million, alongside management commentary highlighting strong Asian demand, particularly in China and India. See our latest analysis for Autoliv. Autoliv’s share price has been volatile, with a 14.90% 1 month share price return contrasting with a 7.34% 3 month share price decline. The 1 year total shareholder return of 33.10%...

Williams-Sonoma (NYSE:WSM) introduced a Pottery Barn Teen x Billabong collection featuring surf inspired, sustainability focused designs. The new collection targets Gen Z consumers and college living spaces with products positioned around coastal style and eco minded materials. WSM also expanded its GreenRow brand through a hospitality partnership with The Inn at Serenbe, bringing its sustainable design into guest experiences. For Williams-Sonoma, known for brands such as Pottery Barn, West...

Why the DIAMOND program milestone matters for Oculis Holding Oculis Holding (NasdaqGM:OCS) reported that the final patients have completed study visits in both pivotal Phase 3 DIAMOND trials of OCS-01 for diabetic macular edema, moving the program toward key late stage readouts. The company plans to share topline data from these registrational studies in June, with a potential new drug application submission targeted for the fourth quarter of 2026, subject to trial outcomes and regulatory...

We'd be surprised if Dave & Buster's Entertainment, Inc. ( NASDAQ:PLAY ) shareholders haven't noticed that the Chief...

Wondering whether Driven Brands Holdings at around US$12.66 is starting to look like value, or if the price still does not quite stack up for you. The stock has been under pressure, with returns of 4.2% over the last week, 0.5% over the past month, a 12.7% decline year to date, and a 22.5% decline over the last year. The 3 year and 5 year returns sit at 58.8% and 55.6% declines respectively. Recent coverage has focused on how the share price performance ties into the broader consumer...

Why Blackbaud is on investors’ radar Without a single headline event driving attention, Blackbaud (BLKB) has still drawn interest as investors weigh its recent share performance against its fundamentals and valuation metrics. The stock last closed at US$37.49, with returns negative over the past year and past 3 months. This has prompted closer scrutiny of how the company’s AI powered software model, revenue base and profitability line up with current pricing. See our latest analysis for...

Wondering whether Thermo Fisher Scientific at around US$469.71 is priced attractively or already demanding a premium? This article walks through the key signals that can help you frame that question more clearly. The stock has had a mixed run, with a 7 day return of a 10.8% decline, a year to date return of a 20.7% decline, yet a 1 year return of 11.1%. This can leave you questioning whether recent moves reflect changing risk perception or a reset in expectations. Recent attention on the...

On 16 April 2026, Klaviyo and Canva announced an expanded integration that lets marketers design full campaigns in Canva and import complete layouts directly into Klaviyo for data-driven personalization and automated delivery. An interesting angle is that more than one in five Klaviyo customers already use the Canva integration, so deeper in-app exposure to Canva’s large user base could meaningfully influence how many brands build and execute campaigns on Klaviyo. Next, we’ll examine how...

Wondering if GameStop at around US$24.95 is priced for a comeback story or still trading mostly on hype? This breakdown will help you connect the share price to the underlying value. The stock has seen mixed returns, with gains of 1.6% over the last week, 12.9% over the last month and 21.0% year to date, while the 1 year return sits at an 8.1% loss and the 5 year return at a 41.8% loss. Recent coverage has continued to focus on GameStop's role as a meme stock and the ongoing interest from...

If you are wondering whether TJX Companies at around US$157 a share still offers value, the starting point is to look closely at what the current price implies about the business. The stock has been relatively steady in the short term, with a 2.3% decline over the last 7 days, a 1.2% return over the last 30 days, a 1.8% return year to date, and a 25.6% return over the last year, alongside multi year returns of 107.5% over 3 years and 138.0% over 5 years. Recent news coverage has focused on...